165 related articles for article (PubMed ID: 28218042)
21. Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells.
Lepore SM; Maggisano V; Lombardo GE; Maiuolo J; Mollace V; Bulotta S; Russo D; Celano M
Endocr Metab Immune Disord Drug Targets; 2019; 19(1):59-66. PubMed ID: 30264682
[TBL] [Abstract][Full Text] [Related]
22. Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells.
Allegri L; Baldan F; Mio C; Puppin C; Russo D; Kryštof V; Damante G
Oncol Rep; 2016 Apr; 35(4):2413-8. PubMed ID: 26884249
[TBL] [Abstract][Full Text] [Related]
23. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.
Durai L; Ravindran S; Arvind K; Karunagaran D; Vijayalakshmi R
Mol Biol Rep; 2021 Nov; 48(11):7443-7456. PubMed ID: 34716862
[TBL] [Abstract][Full Text] [Related]
25. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
26. Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma.
Geng M; Yang Y; Cao X; Dang L; Zhang T; Zhang L
Biochem Biophys Res Commun; 2019 Dec; 520(3):544-550. PubMed ID: 31615655
[TBL] [Abstract][Full Text] [Related]
27. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.
El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F
Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260
[TBL] [Abstract][Full Text] [Related]
28. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
Zhang Y; Li K; Wang W; Han J
Int J Exp Pathol; 2021 Aug; 102(4-5):209-217. PubMed ID: 34719830
[TBL] [Abstract][Full Text] [Related]
29. Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
Garg M; Kanojia D; Mayakonda A; Ganesan TS; Sadhanandhan B; Suresh S; S S; Nagare RP; Said JW; Doan NB; Ding LW; Baloglu E; Shacham S; Kauffman M; Koeffler HP
Sci Rep; 2017 Aug; 7(1):9749. PubMed ID: 28852098
[TBL] [Abstract][Full Text] [Related]
30. Flavonoid Fraction of Citrus reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma Cells.
Celano M; Maggisano V; De Rose RF; Bulotta S; Maiuolo J; Navarra M; Russo D
Nutr Cancer; 2015; 67(7):1183-90. PubMed ID: 26365817
[TBL] [Abstract][Full Text] [Related]
31. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
32. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
Kim TH; Yoo YH; Kang DY; Suh H; Park MK; Park KJ; Kim SH
Int J Oncol; 2009 May; 34(5):1353-62. PubMed ID: 19360347
[TBL] [Abstract][Full Text] [Related]
33. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
[TBL] [Abstract][Full Text] [Related]
35. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
[TBL] [Abstract][Full Text] [Related]
36. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
37. Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
J Endocrinol Invest; 2013 Dec; 36(11):1099-104. PubMed ID: 24084189
[TBL] [Abstract][Full Text] [Related]
38. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Horm Metab Res; 2013 Jun; 45(6):408-14. PubMed ID: 23386415
[TBL] [Abstract][Full Text] [Related]
40. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.
Wang C; Zhang R; Tan J; Meng Z; Zhang Y; Li N; Wang H; Chang J; Wang R
Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
